HERA BIOTECH

hera-biotech-logo

Hera Biotech is a biotechnology company that is mainly developed for women's health and reproductive medicines. The company was founded in 2020 and is headquartered in San Antonio, Texas, United States.

#SimilarOrganizations #People #Financial #Website #More

HERA BIOTECH

Social Links:

Industry:
Biopharma Biotechnology Health Care Pharmaceutical

Founded:
2020-01-01

Address:
San Antonio, Texas, United States

Country:
United States

Website Url:
http://www.herabiotech.com

Total Employee:
1+

Status:
Active

Contact:
2106831069

Total Funding:
1.9 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API LetsEncrypt Font Awesome Apache PHP PHP 7


Similar Organizations

alphazyme-logo

Alphazyme

Alphazyme is a biotechnology company that provides custom molecular biology enzymes, rapid enzyme prototyping, and production solutions.

biochempeg-scientific-inc-logo

Biochempeg Scientific Inc.

Biochempeg is a biotechnology-oriented company dedicated to manufacturing high purityPEG derivatives for academic and commercial use.

cellasic-logo

CellASIC

CellASIC is a biotechnology company that develops microfluidic platform for live cell analysis experiments.

curl-bio-logo

Curl Bio

This company is a Drug Development for Type-II Diabetes and Metabolic Syndrome.

enzyvant-sciences-logo

Enzyvant Sciences

Enzyvant Sciences is a biotechnology company which focuses on developing treatments for rare diseases.

epitope-diagnostics-logo

Epitope Diagnostics

Epitope Diagnostics is a biotechnology company that specializes in chemiluminescence assays and Rapid tests.

epivax-logo

EpiVax

EpiVax is an immunology company developing comprehensive analytical capabilities in the field of computational immunology.

healtheconomicscom-logo

HealthEconomics.Com

HealthEconomics.Com is a website for resources related to healthcare value, health economics, and market access.

khona-scientific-logo

Khona Scientific

Khona Scientific is a biotechnology company that focuses on a proprietary method of biosynthesis production.

leading-biology-inc-logo

leading biology inc

Leading Biology Inc. is an innovative high-tech company which produces bio-products for a wide range of research and medical fields.

luminus-biosciences-logo

Luminus Biosciences

Luminus Biosciences is a biotech drug development company seeking to transform poorly water-soluble molecules into multidrug nanomedicines.

sitari-pharmaceuticals-logo

Sitari Pharmaceuticals

Sitari Pharmaceuticals is a biotechnology company developing treatments for multiple disease indications.

stc-biologics-logo

STC Biologics

STC Biologics is a biotechnology company that offers biologics drug research and development services.

vp-scientific-logo

V&P Scientific

V&P Scientific is a biotechnology company that provides aspirate, dispense, stir viscous liquids, and transfer nanoliters.

vaiomer-logo

Vaiomer

Vaiomer is a biotech company and contract research organization expert in tissue and blood microbiota.


Current Advisors List

somer-baburek_image

Somer Baburek CEO @ Hera Biotech
Board_member

Founder


paul-castella_image

Paul Castella

somer-baburek_image

Somer Baburek

Investors List

coyote-ventures_image

Coyote Ventures

Coyote Ventures investment in Seed Round - Hera Biotech

althea-group-ventures_image

Althea Ventures

Althea Ventures investment in Seed Round - Hera Biotech

kendra-scott-women-s-entrepreneurial-leadership-institute_image

Kendra Scott Women's Entrepreneurial Leadership Institute

Kendra Scott Women's Entrepreneurial Leadership Institute investment in Seed Round - Hera Biotech

stella-angels_image

Stella Angels

Stella Angels investment in Seed Round - Hera Biotech

Official Site Inspections

http://www.herabiotech.com Semrush global rank: 4.25 M Semrush visits lastest month: 2.74 K

  • Host name: 45-33-60-46.ip.linodeusercontent.com
  • IP address: 45.33.60.46
  • Location: Fremont United States
  • Latitude: 37.5625
  • Longitude: -122.0004
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94536

Loading ...

More informations about "Hera Biotech"

About - Hera Biotech

In the US, the annual economic burden of endometriosis due to direct medical care of endometriosis is estimated at ~$80B; a cost that could be dramatically curtailed with accurate, early and non-surgical diagnosis.5 Heraโ€™s โ€ฆSee details»

Hera Biotech - Crunchbase Company Profile & Funding

Hera Biotech is a biotechnology company that is mainly developed for women's health and reproductive medicines.See details»

Hera Biotech Company Profile 2024: Valuation, โ€ฆ

Hera Biotech General Information Description. Developer of definitive tissue-based tests designed to diagnose and stage endometriosis. The company's โ€ฆSee details»

Hera Biotech - LinkedIn

Hera Biotech | 4,008 followers on LinkedIn. Advancing the Standard of Care in Women's Health Diagnostics | Our Vision: To be the world leader in understanding & addressing diagnostic ...See details»

Meet the Team - Hera Biotech

Nationally recognized healthcare leader in employee benefits, value-based care, managing populations in Managed Medicaid, Medicare Advantage, Dual Eligible, and Commercial benefits.See details»

Hera Biotech to Make First Acquisition in the

Jan 3, 2024 SAN ANTONIO & BASEL, Switzerland--(BUSINESS WIRE)--Hera Biotech announced today that it has reached an agreement to acquire the endometriosis diagnostic assets and associated IP of single-cell and ...See details»

This Startup is Creating Better Diagnostic Tools for Endometriosis

Somer is an achievement-oriented strategic thinker with strong communication, presentation and interpersonal skills. Adept at building and maintaining close relationships with key โ€ฆSee details»

San Antonio startup Hera Biotech developing non-invasive ... - TPR

Feb 2, 2024 Baburek founded Hera Biotech in 2020 alongside UT Health San Antonio Professors Bruce Nicholson and Nameer Kirma. She said they were the ones who figured out โ€ฆSee details»

Hera Biotech to Make First Acquisition in the Endometriosis

Jan 3, 2024 SAN ANTONIO & BASEL, Switzerland--(BUSINESS WIRE)-- Hera Biotech announced today that it has reached an agreement to acquire the endometriosis diagnostic โ€ฆSee details»

Hera Biotech to Make First Acquisition in the Endometriosis โ€ฆ

Jan 3, 2024 SAN ANTONIO & BASEL, Switzerland, January 03, 2024--Hera Biotech announced today that it has reached an agreement to acquire the endometriosis diagnostic assets and โ€ฆSee details»

Meet Hera Biotech: The company behind a revolutionary โ€ฆ

Jun 23, 2022 Why We Invested? Endometriosis is a chronic condition that affects 10-20% of women, yet it takes an average of ten years in the US for women to receive a diagnosis. โ€ฆSee details»

Hera Biotech Announces First Patient Enrolled in Endometriosis ...

Jan 3, 2023 For more information, please visit herabiotech.com. For photo and video needs, please contact [email protected]. Contacts. Aquila Mendez-Valdez [email protected] โ€ฆSee details»

Hera Biotech to Acquire Endometriosis Diagnostic Assets from โ€ฆ

Jan 5, 2024 In a stride towards non-surgical endometriosis diagnosis, Hera Biotech has announced its impending acquisition of endometriosis diagnostic assets from Scailyte, a โ€ฆSee details»

Why HERA Biotech? - Hera Biotech

An often-painful, benign condition that is the number one cause of female infertility, endometriosis (endo) is estimated to affect 10-20% of women, aged 15-44 worldwide; 7-13 million in the U.S. โ€ฆSee details»

Hera Biotech - Business Wire

Aug 24, 2022 SAN ANTONIO--(BUSINESS WIRE)--San Antonio-based medical device start-up Hera Biotech has closed an oversubscribed $1.9 million seed financing round to support the โ€ฆSee details»

Hera Biotech Announces First Patient Enrolled in Endometriosis ...

Nov 29, 2022 TAMM Net client Hera BioTech has announced the first patient enrolled in an endometriosis diagnostic study! "TAMM Net, Inc. is honored to be the CRO of choice for this โ€ฆSee details»

Hera Biotech Announces Positive Interim Results From โ€ฆ

SAN ANTONIO, April 23, 2024--Hera Biotech is pleased to report the interim results for its proof-of-concept multi-center clinical trial of the MetriDxโ„ข endometriosis diagnostic test. Per ...See details»

Hera Biotech Announces Positive Interim Results From โ€ฆ

Apr 23, 2024 SAN ANTONIO--(BUSINESS WIRE)-- Hera Biotech is pleased to report the interim results for its proof-of-concept multi-center clinical trial of the MetriDxโ„ข endometriosis โ€ฆSee details»

Hera Biotech Acquires Endometriosis Dx Assets From Scailyte

Jan 3, 2024 NEW YORK โ€“ Hera Biotech said on Wednesday that it has signed an agreement to acquire the endometriosis diagnostic testing assets and associated intellectual property of โ€ฆSee details»

linkstock.net © 2022. All rights reserved